These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19288194)

  • 1. Use of recombinant factor VIIa to correct the coagulation status of individuals with advanced liver disease prior to a percutaneous liver biopsy.
    Sajjad S; Garcia M; Malik A; George MM; Van Thiel DH
    Dig Dis Sci; 2009 May; 54(5):1115-9. PubMed ID: 19288194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).
    Kositchaiwat C; Chuansumrit A
    Thromb Haemost; 2001 Oct; 86(4):1125-6. PubMed ID: 11686340
    [No Abstract]   [Full Text] [Related]  

  • 3. Procoagulant therapeutics in liver disease: a critique and clinical rationale.
    Shah NL; Intagliata NM; Northup PG; Argo CK; Caldwell SH
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):675-82. PubMed ID: 25023035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fresh frozen plasma and recombinant factor VIIa use in neonates.
    Puetz J; Darling G; McCormick KA; Wofford JD
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):901-6. PubMed ID: 19956022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience.
    Pham HP; Hsu SX; Parker-Jones S; Samstein B; Diuguid D; Schwartz J
    Vox Sang; 2014 Jan; 106(1):75-82. PubMed ID: 23815226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy.
    Jeffers L; Chalasani N; Balart L; Pyrsopoulos N; Erhardtsen E
    Gastroenterology; 2002 Jul; 123(1):118-26. PubMed ID: 12105840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
    Stein DM; Dutton RP; Hess JR; Scalea TM
    Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy reversal in intracerebral haemorrhage.
    Sweidan AJ; Singh NK; Conovaloff JL; Bower M; Groysman LI; Shafie M; Yu W
    Stroke Vasc Neurol; 2020; 5(1):29-33. PubMed ID: 32411405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of surgical procedures in children with severe FV deficiency: experience of 13 surgeries.
    Mathias M; Tunstall O; Khair K; Liesner R
    Haemophilia; 2013 Mar; 19(2):256-8. PubMed ID: 23173600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of life-threatening hemorrhages and unsafe interventions in nonhemophiliac children by recombinant factor VIIa.
    Leblebisatan G; Sasmaz I; Antmen B; Yildizdas D; Kilinc Y
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):77-82. PubMed ID: 18838398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
    Ramsey G
    Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury.
    Arnaud F; Hammett M; Philbin N; Scultetus A; McCarron R; Freilich D
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):669-77. PubMed ID: 18832908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?
    McQuay N; Cipolla J; Franges EZ; Thompson GE
    J Neurosurg; 2009 Oct; 111(4):666-71. PubMed ID: 19425887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
    Jimenez-Yuste V; Núñez R; Romero JA; Montoro B; Espinós B
    Haemophilia; 2013 Nov; 19(6):841-6. PubMed ID: 23758100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.